Skip to main content
Fig. 7 | BMC Nephrology

Fig. 7

From: Guidelines adherence in the prevention and management of chronic kidney disease in patients with diabetes mellitus on the background of recent European recommendations – a registry-based analysis

Fig. 7

Proportion of patients using ACEi/ARBs as per guideline recommendation. Legend: A RAAS blocker (ACEi or ARB) is recommended for the treatment of hypertension in patients with diabetes, particularly in the presence of microalbuminuria, proteinuria (macroalbuminuria*), or LVH** [3]. Values are percent with 95 % CIs; *Proteinuria was replaced by macroalbuminuria as this was generally determined; **LVH is not available in the DIVE/DPV dataset

Back to article page